CrushSCI.com
Journal Selection & Manuscript Polishing Services
Brain Tumor Pathology journal cover Medicine
Back to journal directory

Review Cycle Records

Brain Tumor Pathology

Springer SCIE Non-OA
2026 Emerging Zone 32025 CAS Zone 32025 JCR Q2
160.6Average days
154Median days
77Fastest days
290Longest days
282025 publications

Paper Review Records

All Paper Review Records

10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

214 days

Utility of digital PCR for detecting TERT promoter mutations and CDKN2A homozygous deletion in meningioma

AuthorsTakuma Kodama; Yuzaburo Shimizu; Mario Suzuki; Osamu Akiyama; Ikuko Ogino; Koichi Ichimura; Akihide Kondo

Affiliations1. Faculty of Medicine, Department of Neurosurgery, Juntendo University, Tokyo, Japan; 2. Faculty of Medicine, Department of Pathology, Kyorin University, Tokyo, Japan

Source PDF DOI Publisher page
84 days

Feasibility of long-read nanopore sequencing for methylation-based classification of posterior fossa ependymomas

AuthorsSeiji Yamada; Tetsuya Takimoto; Yoshiteru Shimoda; Fumiharu Ohka; Masayuki Kanamori; Kennosuke Karube; Hidenori Endo; Ryuta Saito; Hideyuki Saya; Eiji Sugihara

Affiliations1. Oncology Innovation Center , Research Promotion Headquarters Fujita Health University School of Medicine , Toyoake, Japan; 2. Department of Neurosurgery , Tohoku University Graduate School of Medicine , Miyagi, Japan; 3. Department of Neurosurgery, Nagoya University School of Medicine, Nagoya, Japan; 4. Department of Pathology and Laboratory Medicine , Nagoya University Hospital , Nagoya, Japan; 5. Laboratory of Genome Sequencing and Analysis, Open Facility Center, Fujita Health University School of Medicine, Toyoake, Japan

Source PDF DOI Publisher page
77 days

Comparative molecular profiles of distinct tumor components in recurrent tentorial meningioma after stereotactic radiosurgery: a case report implicating acquired aggressive alterations associated with WHO grade progression

AuthorsTakeru Hirata; Yudai Hirano; Motoyuki Umekawa; Satoru Miyawaki; Yuki Shinya; Hirotaka Hasegawa; Yu Sakai; Noritaka Kudo; Daisuke Komura; Hiroto Katoh; Shumpei Ishikawa; Nobuhito Saito

Affiliations1. Department of Neurosurgery, The University of Tokyo Hospital, Tokyo, Japan; 2. Department of Neurosurgery, University of Virginia, Charlottesville, USA; 3. Department of Pathology, The University of Tokyo Hospital, Tokyo, Japan; 4. Department of Preventive Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan

Source PDF DOI Publisher page
290 days

Exploratory analysis of miRNAs-21, -26a, -34a, -181c, -181d, and -485-5p as potential biomarkers for tumor treating fields sensitivity in primary glioblastoma cell cultures

AuthorsSina Hemmer; Mohamed Henia; Walter Schulz-Schaeffer; Ralf Ketter; Benjamin Landau; Joachim Oertel; Steffi Urbschat

Affiliations1. Department of Neurosurgery, Saarland University Medical Center, Homburg, Germany; 2. Institute for Neuropathology, Saarland University Medical Center, Homburg, Germany; 3. Department of Neurology, Saarland University Medical Center, Homburg, Germany

Source PDF DOI Publisher page
142 days

Late-onset intracranial adenocarcinoma arising from a germ cell tumor 25 years after initial diagnosis

AuthorsYuri Yamagiwa; Masashi Nomura; Hirokazu Takami; Atsushi Kondo; Yosuke Kitagawa; Aya Shinozaki-Ushiku; Shunsaku Takayanagi; Nobuhito Saito

Affiliations1. Department of Neurosurgery, Graduate School of Medicine, The University of Tokyo, Bunkyo-Ku, Tokyo, Japan; 2. Department of Pathology, Graduate School of Medicine, The University of Tokyo, Bunkyo-Ku, Tokyo, Japan; 3. Department of Neurosurgery/Neuro-Oncology, Saitama Medical University International Medical Center, Hidaka-Shi, Saitama, Japan

Source PDF DOI Publisher page
93 days

A rare case of supratentorial ependymosarcoma harboring ZFTA :: RELA fusion

AuthorsYuji Matsumoto; Yasuki Suruga; Kaishi Satomi; Yohei Inoue; Yasuhiko Hattori; Joji Ishida; Kazuhiko Kurozumi; Sumihito Nobusawa; Junko Hirato; Takehiro Tanaka; Hiroyuki Yanai; Kana Washio; Koichi Ichimura; Tomotsugu Ichikawa; Yoshihiro Otani; Shota Tanaka

Affiliations1. Department of Neurological Surgery, Dentistry, and Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Kita-Ku, Japan; 2. Department of Pathology, Faculty of Medicine, Kyorin University, Tokyo, Japan; 3. Department of Neurosurgery, Okayama City Hospital, Okayama, Japan; 4. Department of Neurosurgery, Hamamatsu University Hospital, Hamamatsu, Japan; 5. Department of Human Pathology, Gunma University School of Medicine, Maebashi, Japan; 6. Department of Pathology, Public Tomioka General Hospital, Tomioka, Japan; 7. Department of Pathology, Okayama University Hospital, Okayama, Japan; 8. Department of Pathology, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Okayama, Japan; 9. Department of Pediatrics, Okayama University Hospital, Okayama, Japan; 10. Department of Neurosurgery, Kagawa Prefectural Central Hospital, Takamatsu, Japan

Source PDF DOI Publisher page
154 days

Histopathological evaluation of dopamine receptor D2 expression in symptomatic gonadotroph pituitary neuroendocrine tumors: a case series including a rare metastatic case responsive to a dopamine agonist

AuthorsKen Uekawa; Naoki Shinojima; Takahiro Yamamoto; Shigeo Anai; Kozo Tashima; Motoyuki Igata; Takeshi Matsumura; Rumi Sasaki; Takashi Ohba; Hironori Tashiro; Kazuhito Tanaka; Kentaro Tanaka; Hiroyo Mabe; Shigetoshi Yano; Toshinori Hirai; Yoshiki Mikami; Akitake Mukasa

Affiliations1. Department of Neurosurgery, Kumamoto University Hospital, Kumamoto, Japan; 2. Department of Diabetes, Metabolism and Endocrinology, Kumamoto University Hospital, Kumamoto, Japan; 3. Department of Medical Technology, Faculty of Health Sciences, Kumamoto Health Science University, Kumamoto, Japan; 4. Department of Obstetrics and Gynecology, Kumamoto University Hospital, Kumamoto, Japan; 5. Department of Reproductive Health, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan; 6. Department of Diagnostic Pathology, Kumamoto University Hospital, Kumamoto, Japan; 7. Department of Gastroenterology and Hepatology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan; 8. Department of Pediatrics, Kumamoto University Hospital, Kumamoto, Japan; 9. Department of Neurosurgery, Minamifukuoka Neurosurgical Hospital, Fukuoka, Japan; 10. Department of Diagnostic Radiology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan

Source PDF DOI Publisher page
221 days

Primary sellar glomus tumor with BRAF K601E mutation: an aggressive tumor of uncertain malignant potential

AuthorsBin Mi; Benjamin Ka Seng Thong; Li Jiang; Xue Wang

Affiliations1. Department of Pathology, Pingyi County People’s Hospital, Linyi, China; 2. Shanghai Jiao Tong University School of Medicine, Shanghai, China; 3. Department of Pathology, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China

Source PDF DOI Publisher page
177 days

Gyriform infiltration indicates tumor invasion burden of isocitrate dehydrogenase 1/2-wildtype gliomas

AuthorsHideyuki Arita; Kentaro Hirai; Mio Sakai; Tatsuya Hagioka; Koji Takano; Toru Umehara; Hidenori Yoshizawa; Yoshinori Kodama; Nobuo Kashiwagi; Katsuyuki Nakanishi; Yonehiro Kanemura

Affiliations1. Department of Neurosurgery, Osaka International Cancer Institute, Osaka, Japan; 2. Department of Neurosurgery, Osaka University Graduate School of Medicine, Osaka, Japan; 3. Department of Diagnostic and Interventional Radiology, Osaka International Cancer Institute, Osaka, Japan; 4. Department of Neurosurgery, Hanwa Memorial Hospital, Osaka, Japan; 5. Department of Diagnostic Pathology and Cytology, Osaka International Cancer Institute, Osaka, Japan; 6. Department of Diagnostic Pathology, Osaka University Hospital, Osaka, Japan; 7. Department of Biomedical Research and Innovation, Institute for Clinical Research, NHO Osaka National Hospital, Osaka, Japan; 8. Department of Neurosurgery, NHO Osaka National Hospital, Osaka, Japan

Source PDF DOI Publisher page
154 days

Reappraisal of novel molecular parameters for meningioma grading by cIMPACT-NOW update 8 proposals

AuthorsKenta Masui; Asuka Komori; Shuhei Morita; Seiichiro Eguchi; Takakazu Kawamata; Mayu Kashiwagi-Hakozaki; Atsushi Kurata; Takashi Komori

Affiliations1. Department of Pathology, Tokyo Women’s Medical University, Tokyo, Japan; 2. Department of Integrative Neuroscience, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan; 3. Department of Neurosurgery, Tokyo Women’s Medical University Hospital, Tokyo, Japan; 4. Department of Laboratory Medicine and Pathology, TMG Asaka Medical Center, Saitama, Japan; 5. Department of Laboratory Medicine and Pathology, Tokyo Metropolitan Neurological Hospital, Tokyo, Japan

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.